A4268120
1-(4-ami-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride , >98.0%(HPLC) , 63074-08-8
Synonym(s):
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride;1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride dihydrate;Terazosin hydrochloride dihydrate
CAS NO.:63074-08-8
Empirical Formula: C19H26ClN5O4
Molecular Weight: 423.89
MDL number: MFCD00467965
Pack Size | Price | Stock | Quantity |
5g | RMB177.60 | In Stock |
|
25g | RMB603.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 261-263°C |
storage temp. | Inert atmosphere,2-8°C |
solubility | H2O: 25 mg/mL |
form | powder |
color | white to off-white |
Water Solubility | Soluble in water at 20mg/ml. Also soluble in methanol or ethanol. |
Stability: | Stable for 2 years as supplied. Solutions in distilled water may be stored at -20° for up to 3 months. |
Description and Uses
Terazosin hydrochloride is a highly water-soluble antihypertensive agent with a structure and profile closely related to that of prazosin.
An α-1-adrenergicblocker related to prazosin.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P264-P270-P301+P312-P501 |
Hazard Codes | Xn,Xi |
Risk Statements | 22-36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 3 |
RTECS | TK8044925 |